Aurora Cannabis (ACB) Income from Continuing Operations (2017 - 2025)
Aurora Cannabis (ACB) reported Income from Continuing Operations of 21046482.41 for Q4 2025, down 9.8% year-over-year from 23333566.09 in Q4 2024, and up 111.98% quarter-over-quarter from 9928740.68 in Q3 2025.
Aurora Cannabis (ACB) Income from Continuing Operations (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Income from Continuing Operations data on file, last reported at 21046482.41 in Q4 2025.
- Income from Continuing Operations for Q4 2025 came in at 21046482.41, down 9.8% year-over-year; the trailing twelve-month figure through Dec 2025 was 6435599.38 (down 74.45% YoY), and the FY2025 annual result was 10985494.41, up 125.93% from the prior year.
- Income from Continuing Operations advanced to 21046482.41 in Q4 2025 per ACB's latest filing, from 9928740.68 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 23333566.09 in Q4 2024 and troughed at 795575679.45 in Q1 2022.
- A 5-year average of 89245265.5 and a median of 13684485.89 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations tumbled 543.4% in 2022, then soared 286.49% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 59537600.86 in 2021, then jumped by 32.62% to 40117895.3 in 2022, then surged by 68.81% to 12511920.9 in 2023, then soared by 286.49% to 23333566.09 in 2024, then declined by 9.8% to 21046482.41 in 2025.
- Business Quant data shows ACB's Income from Continuing Operations at 21046482.41 in Q4 2025, 9928740.68 in Q3 2025, and 4975485.97 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 52.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.05 Mn |
| Sep 30, 2025 | 9.93 Mn |
| Jun 30, 2025 | 4.98 Mn |
| Mar 31, 2025 | -29.52 Mn |
| Dec 31, 2024 | 23.33 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 10.54 Mn |
| Mar 31, 2024 | -14.86 Mn |
| Dec 31, 2023 | -12.51 Mn |
| Sep 30, 2023 | 5.69 Mn |
| Dec 31, 2022 | -40.12 Mn |
| Sep 30, 2022 | -39.10 Mn |
| Jun 30, 2022 | -479.27 Mn |
| Mar 31, 2022 | -795.58 Mn |
| Dec 31, 2021 | -59.54 Mn |
| Sep 30, 2021 | -9.40 Mn |
| Jun 30, 2021 | -84.57 Mn |
| Mar 31, 2021 | -123.65 Mn |
| Dec 31, 2020 | -222.32 Mn |
| Sep 30, 2020 | -87.86 Mn |